Impact of JN.1 booster vaccination on neutralisation of SARS-CoV-2 variants KP.3.1.1 and XEC
Prerna Arora, Christine Happle, Amy Kempf, Inga Nehlmeier, Metodi V. Stankov, Alexandra Dopfer‐Jablonka, Georg M. N. Behrens, Stefan Pöhlmann, Markus Hoffmann
Topics & Concepts
Booster (rocketry)NeutralizationVirologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)VaccinationCoronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakPandemicMedicineOutbreakInfectious disease (medical specialty)EngineeringVirusAerospace engineeringDiseasePathologySARS-CoV-2 and COVID-19 ResearchAnimal Virus Infections StudiesCOVID-19 Clinical Research Studies